Ngā hua rapu - Anne‐Christine Bay‐Jensen

Whakamahine hua
  1. 1
    Osteoarthritis year in review 2018: biomarkers (biochemical markers)

    Osteoarthritis year in review 2018: biomarkers (biochemical markers) mā Fatemeh Saberi Hosnijeh, S. Bierma-Zeinstra, Anne‐Christine Bay‐Jensen

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives

    Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives mā Yves Henrotin, Christelle Sanchez, Anne‐Christine Bay‐Jensen, Ali Mobasheri

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover

    Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover mā Rasmus Hjorth Nielsen, Anne‐Christine Bay‐Jensen, I. Byrjalsen, M.A. Karsdal

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Osteoarthritis phenotypes and novel therapeutic targets

    Osteoarthritis phenotypes and novel therapeutic targets mā W.E. van Spil, Olga Kubassova, Mikael Boesen, Anne‐Christine Bay‐Jensen, Ali Mobasheri

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers

    Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers mā Anne‐Christine Bay‐Jensen, Ali Mobasheri, Christian S. Thudium, Virginia B. Kraus, M.A. Karsdal

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study

    Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study mā Anne‐Christine Bay‐Jensen, Adam Platt, I. Byrjalsen, Philippe Vergnoud, Claus Christiansen, M.A. Karsdal

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis - the effect of sex, Kellgren-Lawrence (KL) score, Body Mass Index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation

    Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis - the effect of sex, Kellgren-Lawrence (KL) score, Body Mass Index (BMI), oral salmon ca... mā M.A. Karsdal, I. Byrjalsen, Anne‐Christine Bay‐Jensen, Kim Henriksen, BJ Riis, Claus Christiansen

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Osteoarthritis Year in Review 2016: biomarkers (biochemical markers)

    Osteoarthritis Year in Review 2016: biomarkers (biochemical markers) mā Ali Mobasheri, Anne‐Christine Bay‐Jensen, W.E. van Spil, Jonathan Larkin, Marc C. Levesque

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Osteoarthritis – a case for personalized health care?

    Osteoarthritis – a case for personalized health care? mā M.A. Karsdal, Claus Christiansen, C. Ladel, Kim Henriksen, Virginia B. Kraus, Anne‐Christine Bay‐Jensen

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats

    Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats mā Sanne Skovgård Veidal, Efstathios Vassiliadis, Anne‐Christine Bay‐Jensen, Gervais Tougas, Ben Vainer, M.A. Karsdal

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study

    Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study mā Anne‐Christine Bay‐Jensen, Adam Platt, Anne Sofie Siebuhr, Claus Christiansen, I. Byrjalsen, M.A. Karsdal

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation – divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation

    MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation – divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradatio... mā B.C. Søndergaard, N. Schultz, S.H. Madsen, Anne‐Christine Bay‐Jensen, Moustapha Kassem, M.A. Karsdal

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Misbalance in type <scp>III</scp> collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease

    Misbalance in type <scp>III</scp> collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease mā Wouter T. van Haaften, Joachim Høg Mortensen, M.A. Karsdal, Anne‐Christine Bay‐Jensen, Gerard Dijkstra, Peter Olinga

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Recent advances in understanding the phenotypes of osteoarthritis

    Recent advances in understanding the phenotypes of osteoarthritis mā Ali Mobasheri, Simo Saarakkala, Mikko Finnilä, M.A. Karsdal, Anne‐Christine Bay‐Jensen, W.E. van Spil

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Biomarkers for osteoarthritis: Current status and future prospects

    Biomarkers for osteoarthritis: Current status and future prospects mā Ali Mobasheri, Christian S. Thudium, Anne‐Christine Bay‐Jensen, Tazio Maleitzke, Sven Geißler, Georg N. Duda, Tobias Winkler

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation

    The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation mā N. Charni-Ben Tabassi, Sylvie Desmarais, Anne‐Christine Bay‐Jensen, Jean‐Marie Delaissé, M. David Percival, Patrick Garnero

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    A machine learning approach for the identification of new biomarkers for knee osteoarthritis development in overweight and obese women

    A machine learning approach for the identification of new biomarkers for knee osteoarthritis development in overweight and obese women mā Nicola Lazzarini, J. Runhaar, Anne‐Christine Bay‐Jensen, Christian S. Thudium, S.M. Bierma-Zeinstra, Yves Henrotin, Jaume Bacardit

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Collagen degradation products measured in serum can separate ovarian and breast cancer patients from healthy controls: A preliminary study

    Collagen degradation products measured in serum can separate ovarian and breast cancer patients from healthy controls: A preliminary study mā Cecilie Liv Bager, Nicholas Willumsen, Diana Julie Leeming, Victoria Smith, M.A. Karsdal, David Dornan, Anne‐Christine Bay‐Jensen

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Suppression of T Cell Activation and Collagen Accumulation by an Anti-IFNAR1 mAb, Anifrolumab, in Adult Patients with Systemic Sclerosis

    Suppression of T Cell Activation and Collagen Accumulation by an Anti-IFNAR1 mAb, Anifrolumab, in Adult Patients with Systemic Sclerosis mā Xiang Guo, Brandon W. Higgs, Anne‐Christine Bay‐Jensen, M.A. Karsdal, Yihong Yao, Lorin Roskos, Wendy I. White

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls

    Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls mā Nicholas Willumsen, Cecilie Liv Bager, Diana Julie Leeming, Victoria Smith, M.A. Karsdal, David Dornan, Anne‐Christine Bay‐Jensen

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: